Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative medicines to improve the lives of people with metabolic deseases.
Patient Resources | Email Sign-up | Contact Us
Home About Us Pipeline Research Investors Careers  
Challenging Science. Changing Lives.

Investor Relations
News, SEC filings, presentation archives, stock information
Research Capabilities
Career Opportunities
Strategic Alliances
Development Pipeline
THERAPEUTIC FOCUS Diabetes Obesity

Amylin is dedicated to improving lives through the discovery, development and commercialization of innovative medicines for the treatment of diabetes and obesity.

Download our Annual Report
Annual Report

View or download our current annual report.
View and download annual report
View the online annual report

News and Events
Morgan Stanley Global Healthcare Conference (NY)

Morgan Stanley Global Healthcare Conference (NY)
Tuesday, September 9, 2008 (7:55 a.m. PT/10:55 a.m. ET)

  

BioCentury NewsMakers Conference (NY)
Thursday, September 4, 2008 (8:30 a.m. PT/11:30 a.m. ET)

  

Thomas Weisel Healthcare Conference (Boston)
Wednesday, September 3, 2008 (6:10 a.m. PT/9:10 a.m. ET)

  

REPLAY: Amylin/Lilly Webcast (FDA BYETTA Advisory)
Tuesday, August 26, 2008 (2:00 p.m. PT/5:00 p.m. ET)

More News » More Events »

Home | About Us | Pipeline | Research | Investors | Careers
  		Site Map | Terms of Use | Updates | PRIVACY
© 2006 Amylin Pharmaceuticals, Inc. - All Rights Reserved